Alain Aspect helped turn a profound disagreement about reality into an experiment. Decades later, a company he co-founded faces a question with more familiar consequences: what can customers actually do with a quantum computer?

Pasqal completed its public-market transaction on August 27, bringing fresh capital to its effort to put quantum processors to work. Days later, it announced a research milestone involving something far more tangible than a stock-market debut: the behavior of proteins in food. Pasqal’s transaction announcement

The distance between those two announcements is the story. Money can help build machines. Their usefulness has to emerge from the problems they solve.

From a scientific argument to a machine

Aspect shared the 2022 Nobel Prize in Physics with John Clauser and Anton Zeilinger for work involving quantum entanglement. His experiments helped establish that the correlations between entangled particles cannot be explained by the kind of local hidden-variable account tested through Bell inequalities. His career also encompasses laser cooling, ultracold atoms and quantum simulators. École polytechnique’s account of his work

That history connects fundamental physics with the ability to control matter in extraordinary detail. It also makes Aspect a compelling public face for a technology that is usually represented by machinery most readers cannot decipher.

A Nobel Prize recognizes a scientific contribution. The engineering and commercial case for each subsequent machine still needs its own evidence.

Pasqal said its completed combination with Bleichroeder Acquisition Corp. II left approximately $360 million available at closing. It reported seven quantum processing units deployed and three more in production. The company plans to expand manufacturing, cloud access and integration with conventional high-performance computing while developing more resilient hardware. Pasqal’s August 27 announcement

Building a functioning processor, installing it and improving a customer’s work are separate achievements. Progress becomes easier to understand when each is measured on its own terms.

What the atoms have to accomplish

Pasqal uses tightly focused laser beams, known as optical tweezers, to hold and control individual rubidium atoms. Those atoms provide the physical basis for its processors. Around them sits a larger system of vacuum equipment, controls, software and connections to the computing infrastructure customers already operate. Inside Pasqal’s technology

The result is a specialized instrument that has to earn its place within an existing workflow. A customer needs to know which part of a problem reaches the quantum machine, what conventional computers still handle, and whether the combined process produces a worthwhile result.

A technically elegant demonstration can be valuable research before it answers those commercial questions. Keeping that distinction clear gives useful experiments room to develop without asking them to carry promises they have not earned.

A possible destination: the food on your plate

On September 2, Pasqal and True Nexus announced that they had used neutral-atom quantum technology to encode selected protein structures relevant to gelation—the process through which liquids form gels. Their stated ambition is to better understand how protein structure influences behavior in food applications. The protein collaboration announcement

A protein ingredient has to perform in a product. Texture and structure matter alongside its molecular description. The companies hope that combining AI-based protein analysis with quantum computing can help connect those levels.

For now, the announced milestone is encoding selected structures. The release does not provide a comparative benchmark showing an advantage over the best conventional methods, or demonstrate a new food ingredient successfully designed and validated through the approach.

The next evidence would be especially interesting: a prediction tested against real protein behavior, a clearly described comparison and a result that remains useful beyond the initial example. That would make the connection to everyday life much firmer.

A standard the company can be held to

Researchers from IBM and Pasqal have proposed a framework that puts two requirements at the center of quantum advantage: the output must be rigorously validated, and the quantum approach must demonstrate superior efficiency, cost-effectiveness or accuracy compared with conventional computation alone. A framework for quantum advantage

Their paper treats an advantage claim as something open to challenge. Improved classical methods can change the comparison. A convincing result needs to survive that scrutiny, rather than depend on a competitor standing still.

That suggests useful questions for readers: what task was completed, how was the answer checked, and how strong was the comparison? A bigger processor can be scientifically interesting. A verified improvement on a consequential task makes its relevance easier to see.

Pasqal’s roadmap targets more than 200 logical qubits by 2029. Logical qubits use error correction to protect quantum information. That goal describes a future capability, rather than dependable computational units already available to customers. Pasqal’s roadmap

The nearer test is whether deployed systems produce increasingly transparent, repeatable results on useful problems. Protein research offers one place to look. The details of a customer’s workflow offer another.

Aspect’s scientific legacy makes Pasqal worth following. Its next chapter will be judged by the work its machines help people accomplish.

How this article was made

This analysis was prepared using AI-assisted research and drafting, with checks against the linked public documents. Company announcements and future targets are identified as such. Publication was authorized by the publisher. No original interview, independent hardware test or separate human fact-check is claimed.

Photograph

Alain Aspect, archival photograph. © École polytechnique / Institut Polytechnique de Paris / J. Barande. CC BY-SA 2.0. Resized and converted to WebP. Image source, license.